NEW YORK, July 28 - PerkinElmer reported nearly flat revenues and income for the second quarter last week, amid a dip in its life sciences revenues.
The company's revenues for the quarter totaled of $377.1 million, compared to $383.1 million for the second quarter of 2002.
The revenues for the company's life and analytical sciences business came to $246 million, compared to $250 million in the same period last year, Robert Friel, the company's chief financial officer, said in a conference call to discuss the company's quarterly results.
Income for the quarter was $8.4 million, compared to $9.1 million for the year-ago quarter.
The company's R&D expenses came to $21.9 million, compared to $22.6 million for the second quarter of 2002.
As of June 30, PerkinElmer had $144.6 million in cash and cash equivalents.